RXST — RxSight, Inc.

—
Nasdaq · Unknown · Unknown · CIK 1111485 ·
Last close
$4.83
Market Cap
$202.52M
52W High
$13.22
52W Low
$4.11
ADV30
879,225
Next earnings
2026-11-03

Quarterly Fundamentals

Revenues vs Net Income (last 4 Q)

Assets vs Liabilities (last 4 Q)

PeriodRevenuesGross profitOp incomeNet incomeAssetsCashLiabilities
Sep 2026 24,586,000 18,099,000 -18,518,000 -16,224,000 340,418,000 66,717,000 85,507,000
Jun 2026 33,741,000 25,886,000 -13,770,000 -12,097,000 352,700,000 13,352,000 89,360,000
Mar 2026 30,893,000 23,498,000 -17,829,000 -15,884,000 303,993,000 17,573,000 36,698,000
Dec 2025 32,608,000 25,263,000 -11,337,000 -9,152,000 311,814,000 19,949,000 36,131,000

Cashflow TTM (yfinance, fills SEC gap)

Operating CF
$23,671,000
Investing CF
$11,832,000
Financing CF
$1,584,000
CapEx
$-5,026,000
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$-1.28
As of
2026-11-08

Balance + Analyst (yfinance extras)

Retained Earnings
$-705,244,000
Inventory
$39,593,000
Receivables
$16,998,000
ST Investments
$187,966,000
EBIT TTM
$-53,216,000
Pretax Income TTM
$-53,230,000
Interest Exp TTM
$14,000
Analysts
8

Yahoo Snapshot (yfinance, live)

Total Revenue
$121,828,000
EBITDA
$-57,842,000
Free Cash Flow
$39,379,876
Enterprise Value
$-54,004,332
Total Cash
$254,683,008
Total Debt
$10,320,000
Shares Out
41,929,222
Trailing EPS
$-1.29
Book Value
$6.08
ROE
-20.1%
ROA
-11.8%
Div Yield
0.00%

Annual Trend (SEC EDGAR, last 4y)

Revenues vs Net Income (last 4y)

FY endRevenuesOp incomeNet incomeAssetsLiabilitiesEquityOp cash flow
Dec 2025 134,479,000 -48,191,000 -38,944,000 311,814,000 36,131,000 275,683,000 -15,511,000
Dec 2024 139,927,000 -36,858,000 -27,455,000 318,563,000 37,325,000 281,238,000 -16,946,000
Dec 2023 89,077,000 -50,085,000 -48,608,000 182,550,000 22,188,000 160,362,000 -41,593,000
Dec 2022 49,005,000 -63,318,000 -66,756,000 150,164,000 60,262,000 89,902,000 -58,850,000

TTM Snapshot

Revenues TTM
$127,581,000
NetIncome TTM
$-46,949,000
OpCashFlow TTM
—
Assets (Latest)
$352,700,000
Forward EPS
$-0.68

Max Pain — expiry 2027-03-19 (volume-derived — Yahoo OI feed degraded)

max pain strike: $7.50 · spot: $5.01 · call volume: 8 · put volume: 49
Expected Move to 2027-03-19: ±$1.98 (39.42%) — implied range $3.04 – $6.99 · ATM straddle on $5.00 strike

Peers — same industry

TickerNameMarket CapLastDaily %
UURAF Ucore Rare Metals Inc. $202.25M $1.33 —
KF KOREA FUND INC $202.93M $48.80 —
TDRRF Tudor Gold Corp. $202.03M $0.49 —
QSI Quantum-Si Inc $201.80M $1.01 —
LIEN Chicago Atlantic BDC, Inc. $201.73M $8.84 —

News headlines (Yahoo Finance, 1h cache)

RxSight (RXST) Q3 2026 Earnings Call Transcript
2026-11-04 17:05 · Yahoo
RxSight, Inc. Q3 2026 Earnings Call Summary
2026-11-04 13:30 · Yahoo
What RxSight (RXST) Said on Its Q3 Earnings Call
2026-11-04 03:14 · Yahoo
RxSight, Inc. (RXST) Reports Q3 Loss, Lags Revenue Estimates
2026-11-03 21:50 · Yahoo
RxSight, Inc. Reports Third Quarter 2026 Results
2026-11-03 21:05 · Yahoo
RxSight Reports Inducement Grants as Permitted by the Nasdaq Listing Rules
2026-10-24 00:00 · Yahoo
RxSight, Inc. to Report Third Quarter 2026 Financial Results on November 3
2026-10-20 20:05 · Yahoo
RxSight Appoints Eye Care Industry Leaders to Drive Commercial Transformation
2026-10-19 13:00 · Yahoo
RxSight's Utilization-Growth Upside Faces Structural, Competitive Headwinds, BofA Says
2026-09-23 14:42 · Yahoo
RxSight, Inc. to Participate in the Wells Fargo Healthcare Conference
2026-08-26 20:15 · Yahoo

Recent Insider Activity

No insider activity indexed for this ticker.